Hepatic Cancer Clinical Trials

7 recruitingLast updated: June 17, 2026

There are 7 actively recruiting hepatic cancer clinical trials across 6 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 4. Top locations include Duarte, California, United States, Fort Worth, Texas, United States, Fukuoka, Japan. Updated daily from ClinicalTrials.gov.


Hepatic Cancer Trials at a Glance

7 actively recruiting trials for hepatic cancer are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Duarte, Fort Worth, and Fukuoka. Lead sponsors running hepatic cancer studies include City of Hope Medical Center, Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc., and Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

Browse hepatic cancer trials by phase

Treatments under study

About Hepatic Cancer Clinical Trials

Looking for clinical trials for Hepatic Cancer? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hepatic Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hepatic Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 1

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Gastric CancerHead and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)+9 more
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.40 enrolled3 locationsNCT07517198
Recruiting

An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer

CholangiocarcinomaHepatocellular CarcinomaHepatic Carcinoma+4 more
City of Hope Medical Center400 enrolled5 locationsNCT06342414
Recruiting
Not Applicable

Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals

Risk of Breast CancerRisk of Gynaecological CancerRisk of Colorectal Cancer+14 more
Gustave Roussy, Cancer Campus, Grand Paris5,909 enrolled1 locationNCT06907095
Recruiting
Not Applicable

Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery

Gynecologic CancersColorectal, CancerBiliary Tract Cancer+8 more
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)48 enrolled1 locationNCT06731998
Recruiting
Not Applicable

Immunohistochemical Algorithm for the Diagnosis and Classification of Hepatocellular Carcinomas With TERT, TP53 and CTNNB1 Mutation

Hepatic CancerHepatic Resection
IRCCS Azienda Ospedaliero-Universitaria di Bologna100 enrolled1 locationNCT06718153
Recruiting
Phase 2

Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma.

SurgeryHepatic Cancer
Second Affiliated Hospital of Guangzhou Medical University90 enrolled1 locationNCT06492408
Recruiting
Phase 4

Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery

Prostate CancerArthritis KneeSpine Fusion+2 more
Konkuk University Medical Center148 enrolled1 locationNCT05957822